This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Todd Amrhein Award-winning Director of Global Training, Learning and Development, Marketing, and Sales About Todd Amrhein : Todd is a results-driven, award-winning Director of Global Training, Learning and Development, Marketing, and Sales in the biotechnology and pharmaceutical industry.
This effort seeks to provide the pharmaceutical industry with more accurate representation of patient populations, thereby enhancing the safety and efficacy for prescription drugs and medical devices. Hence, pharmaceutical companies need to start making preparations to ensure compliance with the new requirements.
Strategies for Market Access Teams One thing the healthcare ecosystem lacks in the United States is a system of shareable, actionable healthcare data. How do pharmaceutical companies work with payers? For more information about understanding payer and patient utilization trends, request a demo. The answer is payers and claims.
Drug Pricing, Global Diversity Strategies, & Emerging AI Applications Each year, we compile our predictions to provide life sciences, pharmaceutical, and healthcare organizations with a comprehensive look at emerging industry trends and dynamics to help them prepare for the year ahead.
Trusted Advisors for Scientific Exchange As pharmaceuticals strive to create medications that are more effective and accessible, it’s essential that they engage HCPs early in order to understand the needs of their target audiences.
Every day, patients around the globe are waiting for life-saving treatments to reach the market. However, despite these commitments, recent investigations indicate significant scope for improvements in data sharing by the pharmaceutical industry.
Predictive analytics has been gaining traction as a powerful tool in pharmaceuticals and biotechnology over the past few years, but its potential has yet to be fully realized when it comes to international clinical trials. Request a demo of Trial Landscape.
Aside from some very brief demos on code generation and literature searches, mentions of LLM applications in preclinical research were scarce. The authors provided examples where GPT-4 could provide a SMILES string, IUPAC name, or descriptive text for a marketed drug. Most of the drug discovery examples were underwhelming.
Every year, we take a look at annual predictions to help life sciences, pharmaceutical, and healthcare companies understand larger industry trends and dynamics to prepare for the new year. These forecasts, curated by our own experts and thought leaders, shed light on the changes set to reshape the healthcare and pharmaceutical sectors.
Expected Action Description of action Date Eudamed Module: Market Surveillance [E.U.] Completed development of the EUDAMED Market Surveillance module Q4 2023 Designation of E.U. Expected Action Description of action Original Deadline Pharmaceuticals – changes to marketing authorisations (review of EU rules) [E.U.]
Together, we have created a transformative data platform that integrates the strengths of both companies to serve the healthcare industryfrom health plans and digital health innovators, to pharmaceutical companies, biotechs, CROs, and beyond.For our customers this is going to have an incredible impact.
We organize all of the trending information in your field so you don't have to. Join 15,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content